Brief: Lexaria Bioscience Says On Oct 17 Got Nasdaq Bid Price Deficiency Notice
Oct 18 (Reuters) - Lexaria Bioscience Corp LEXX.O :
* LEXARIA BIOSCIENCE CORP - ON OCTOBER 17 GOT NASDAQ BID
PRICE
DEFICIENCY NOTICE
* LEXARIA BIOSCIENCE CORP - MAY, IF APPROPRIATE, EFFECT
REVERSE
STOCK SPLIT, APPROVED BY SHAREHOLDERS AT SPECIAL MEETING HELD ON
OCTOBER 10
Further company coverage: LEXX.O
((Reuters.Briefs@thomsonreuters.com;))